X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
indans - pharmacology (2003) 2003
animals (1739) 1739
male (1586) 1586
humans (1537) 1537
pharmacology & pharmacy (1033) 1033
rats (994) 994
indans - therapeutic use (832) 832
female (766) 766
donepezil (694) 694
piperidines - pharmacology (674) 674
neurosciences (537) 537
cholinesterase inhibitors - pharmacology (516) 516
piperidines - therapeutic use (499) 499
dose-response relationship, drug (497) 497
alzheimer disease - drug therapy (488) 488
aged (465) 465
alzheimer's disease (464) 464
mice (456) 456
indans - administration & dosage (425) 425
alzheimers-disease (391) 391
indans - chemistry (384) 384
cholinesterase inhibitors - therapeutic use (369) 369
rats, sprague-dawley (349) 349
middle aged (348) 348
indans - adverse effects (315) 315
double-blind (296) 296
psychiatry (291) 291
clinical neurology (282) 282
chemistry, medicinal (266) 266
adult (252) 252
treatment outcome (250) 250
structure-activity relationship (247) 247
dementia (234) 234
rats, wistar (230) 230
indans - pharmacokinetics (222) 222
indans - chemical synthesis (220) 220
time factors (213) 213
biochemistry & molecular biology (211) 211
aged, 80 and over (202) 202
double-blind method (195) 195
analysis (193) 193
piperidines - administration & dosage (190) 190
disease models, animal (185) 185
rivastigmine (184) 184
neuroprotective agents - pharmacology (181) 181
nootropic agents - therapeutic use (172) 172
piperidines - adverse effects (170) 170
in vitro techniques (168) 168
rasagiline (166) 166
drug therapy (165) 165
brain - drug effects (163) 163
parkinson's disease (161) 161
acetylcholinesterase (151) 151
memory (151) 151
brain (147) 147
efficacy (146) 146
indenes - pharmacology (146) 146
cells, cultured (141) 141
cholinesterase-inhibitors (141) 141
molecular structure (141) 141
neuroprotection (134) 134
nootropic agents - pharmacology (134) 134
parkinson disease - drug therapy (134) 134
cholinesterase inhibitors - administration & dosage (133) 133
cholinesterase inhibitors (132) 132
monoamine oxidase inhibitors - pharmacology (132) 132
indans - metabolism (131) 131
cholinesterase inhibitors - adverse effects (130) 130
acetylcholinesterase - metabolism (129) 129
brain - metabolism (128) 128
drug interactions (128) 128
cognition - drug effects (126) 126
administration, oral (125) 125
acetylcholine (124) 124
pharmacology/toxicology (124) 124
placebo-controlled trial (121) 121
stereoisomerism (120) 120
research (119) 119
blood pressure - drug effects (117) 117
rat (117) 117
behavior, animal - drug effects (116) 116
neurology (116) 116
endothelin receptor antagonists (111) 111
maze learning - drug effects (111) 111
pharmacology (111) 111
geriatrics & gerontology (110) 110
safety (106) 106
drug therapy, combination (105) 105
piperidines - pharmacokinetics (105) 105
acetylcholinesterase inhibitors (104) 104
medicine & public health (103) 103
kinetics (102) 102
memory - drug effects (101) 101
neuropsychological tests (101) 101
cognition disorders - drug therapy (100) 100
expression (100) 100
hippocampus - drug effects (100) 100
enzyme inhibitors - pharmacology (98) 98
neurons (97) 97
piperidines - chemistry (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3020) 3020
Japanese (81) 81
German (20) 20
Chinese (16) 16
French (14) 14
Spanish (12) 12
Russian (6) 6
Polish (4) 4
Hungarian (2) 2
Italian (2) 2
Portuguese (2) 2
Ukrainian (2) 2
Finnish (1) 1
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 12/2005, Volume 315, Issue 3, pp. 1346 - 1353
Journal Article
Psychopharmacology (Berlin, Germany), ISSN 1432-2072, 2012, Volume 226, Issue 2, pp. 357 - 369
Journal Article
British journal of pharmacology, ISSN 0007-1188, 2009, Volume 147, Issue S1, pp. S287 - S296
Journal Article
BMC neuroscience, ISSN 1471-2202, 03/2006, Volume 7, Issue 1, pp. 28 - 28
Journal Article
Psychopharmacology, ISSN 0033-3158, 4/2016, Volume 233, Issue 7, pp. 1235 - 1243
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2015, Volume 232, Issue 1, pp. 305 - 314
.... Here, we report new data on the receptor pharmacology of GSK121498, in comparison to naltrexone, naloxone, 6-β... 
μ-Opioid receptor | GSK1521498 | Neurosciences | Biomedicine | Pharmacology/Toxicology | Psychiatry | Inverse agonism | CELLS | RAT | MORPHINE | PSYCHIATRY | TOLERANCE | G-PROTEINS | NEUROSCIENCES | CHRONIC EXPOSURE | mu-Opioid receptor | 6-BETA-NALTREXOL | PHARMACOLOGY & PHARMACY | DOSE SAFETY | MODULATION | AGONIST | Naltrexone - analogs & derivatives | Naltrexone - therapeutic use | Cricetulus | Humans | Analgesics, Opioid - pharmacology | Male | Indans - therapeutic use | Compulsive Behavior - metabolism | Naltrexone - pharmacology | Narcotic Antagonists - metabolism | Compulsive Behavior - drug therapy | HEK293 Cells | CHO Cells | Naltrexone - metabolism | Triazoles - therapeutic use | Cricetinae | Naloxone - metabolism | Morphine - pharmacology | Receptors, Opioid, mu - metabolism | Indans - metabolism | Morphine - metabolism | Analgesics, Opioid - therapeutic use | Naloxone - therapeutic use | Treatment Outcome | Receptors, Opioid, mu - antagonists & inhibitors | Triazoles - pharmacology | Triazoles - metabolism | Guanosine 5'-O-(3-Thiotriphosphate) - metabolism | Animals | Narcotic Antagonists - therapeutic use | Naloxone - pharmacology | Narcotic Antagonists - pharmacology | Ligands | Mice | Analgesics, Opioid - metabolism | Reward | Morphine - therapeutic use | Indans - pharmacology | Protein Binding - physiology | Care and treatment | Compulsive eating | Morphine | Dosage and administration | Pharmacology | Research | Diagnosis | Narcotics | Antagonist drugs | Psychopharmacology | Original Investigation
Journal Article
CNS & neurological disorders drug targets, ISSN 1871-5273, 2017, Volume 16, Issue 7, pp. 800 - 811
Journal Article
Neuroscience, ISSN 0306-4522, 2012, Volume 226, pp. 62 - 72
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 01/2009, Volume 156, Issue 1, pp. 173 - 180
Background and purpose:  Galantamine, a weak acetylcholine esterase (AChE) inhibitor and allosteric potentiator of nicotinic ACh receptors (nAChRs), improves... 
ACh release | apomorphine | muscarinic ACh receptor (mAChR) | dopamine release | donepezil | prepulse inhibition | galantamine | AChE inhibitor | Dopamine release | Galantamine | Donepezil | Apomorphine | Muscarinic ACh receptor (mAChR) | Prepulse inhibition | ACOUSTIC STARTLE REFLEX | FREELY MOVING RATS | PHARMACOLOGICAL CHARACTERIZATION | FRONTAL-CORTEX | CHOLINESTERASE-INHIBITORS | HIPPOCAMPAL ACETYLCHOLINE-RELEASE | EXTRACELLULAR ACETYLCHOLINE | IN-VIVO | MEDIAL PREFRONTAL CORTEX | PHARMACOLOGY & PHARMACY | REARING-INDUCED DEFICITS | Oxotremorine - pharmacology | Muscarinic Agonists - pharmacology | Male | Acetylcholine - metabolism | Nicotinic Antagonists - pharmacology | Galantamine - pharmacology | Behavior, Animal | Dose-Response Relationship, Drug | Drug Interactions | Prefrontal Cortex - drug effects | Apomorphine - pharmacology | Piperidines - pharmacology | Muscarinic Antagonists - pharmacology | Mecamylamine - pharmacology | Reflex, Startle - drug effects | Animals, Outbred Strains | Pirenzepine - pharmacology | Dopamine - metabolism | Inhibition (Psychology) | Dopamine Agonists - pharmacology | Acoustic Stimulation | Pirenzepine - analogs & derivatives | Benzazepines - pharmacology | Animals | Microdialysis | Cholinesterase Inhibitors - pharmacology | Dopamine Antagonists - pharmacology | Serotonin - metabolism | Prefrontal Cortex - metabolism | Mice | Indans - pharmacology | Receptors, Muscarinic - physiology | Index Medicus | Research Papers
Journal Article
Psychopharmacology, ISSN 0033-3158, 6/2015, Volume 232, Issue 11, pp. 1859 - 1866
Journal Article
PloS one, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158808
Many G protein-coupled receptors have been shown to be sensitive to the presence of sodium ions (Na+). Using radioligand competition binding assays, we have... 
Nitriles - pharmacology | Humans | Receptors, Dopamine D3 - metabolism | Piperazines - metabolism | Piperazines - chemistry | Sodium - metabolism | Receptors, Dopamine D2 - metabolism | Biphenyl Compounds - metabolism | Spodoptera | Receptors, Dopamine D3 - genetics | Indoles - metabolism | Sf9 Cells | Biphenyl Compounds - pharmacology | Piperidines - pharmacology | Tetrahydroisoquinolines - chemistry | Dopamine Antagonists - metabolism | Indoles - pharmacology | Molecular Structure | Biphenyl Compounds - chemistry | Radioligand Assay | Dopamine Agonists - metabolism | Binding, Competitive | Indans - chemistry | Dopamine Agonists - pharmacology | Nitriles - metabolism | Tetrahydroisoquinolines - pharmacology | Piperidines - chemistry | Piperidines - metabolism | Receptors, Dopamine D2 - agonists | Indans - metabolism | Ions - metabolism | Piperazines - pharmacology | Receptors, Dopamine D2 - genetics | Receptors, Dopamine D3 - agonists | Animals | Dopamine Antagonists - pharmacology | Tetrahydroisoquinolines - metabolism | Dopamine D2 Receptor Antagonists - metabolism | Nitriles - chemistry | Cell Line, Tumor | Dopamine D2 Receptor Antagonists - pharmacology | Ligands | Mutation | Indoles - chemistry | Indans - pharmacology | G protein-coupled receptors | Mental disorders | Infections | Antagonists | Assaying | Proteins | Psychosis | Psychotropic drugs | Signal transduction | Receptors | Drug therapy | Buffers | Dopamine D2 receptors | Binding | Dopamine | Therapeutic applications | Cloning | Dopamine D3 receptors | Ions | Clozapine | Spiperone | Sensitivity | Sodium | Ionic strength | Pharmacy | Inverse agonists | Affinity | Cations
Journal Article